C P Genain, S S Zamvil. Show Affiliations »
Abstract
Mesh: See more » Clinical Trials as TopicDose-Response Relationship, DrugHumansImmunotherapy/methodsLigandsMultiple Sclerosis/immunologyMultiple Sclerosis/pathologyMultiple Sclerosis/therapyMyelin Basic Protein/immunologyMyelin Basic Protein/metabolismPeptide Fragments/immunologyPeptide Fragments/metabolismPeptide Fragments/therapeutic useTh1 Cells/drug effectsTh2 Cells/drug effectsTh2 Cells/immunology
Substances: See more » LigandsMyelin Basic ProteinPeptide Fragmentsmyelin basic protein 83-99
Year: 2000 PMID: 11017135 DOI: 10.1038/80424
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 53.440